My last posting about targeted alpha therapy discussed the expense of preparing a sample of radioactive actinium, aside from which, targeted alpha therapy should be a very effective and specific and hopefully affordable cancer therapy. Quentin Pankhurst of the London Centre for Nanotechnology has been working with particles of iron oxide, which has very low toxicity and can be attached to antibodies just like the actinium atoms in cages. Iron oxide can be magnetized so each particle can be a permanent magnet. A magnetized particle can then be detected from outside the body using a weak EM field generated by a hand-held device, or it can be heated with a strong EM field, to the point of destroying the cancer cell .
By combining the iron oxide particle with an antibody for the HER2 protein found in breast cancer cells, Pankhurst should be able to achieve the same specificity and effectiveness that Sloan-Kettering has gotten with radioactive actinium, at vastly lesser cost. In order to commercialize this and related applications, Pankhurst has founded Endomagnetics, a start-up based in Houston, Texas.
Why should iron oxide be so much less expensive than radioactive actinium? "Iron oxide" is the chemical name for rusty metal, which is easy to make and store, and readily available in auto scrap yards everywhere. Actinium-225, the isotope used for TAT, has a half-life of ten days, so you can't make a big batch and store some for later use. According to this website at the Oak Ridge National Laboratory: "The actinium-225 is formed from radioactive decay of radium-225, the decay product of thorium-229, which is obtained from decay of uranium-233. The National depository of uranium-233 is at ORNL, and we have developed effective methods for obtaining thorium-229 (half-life 7340 years) as our feed material to routinely obtain actinium-225."
Sunday, April 27, 2008
Monday, April 21, 2008
Targeted alpha therapy
This is something I read about in 2001, and it still seems to be one of the most promising ideas in cancer therapy. The treatment involves two molecular objects bound together. One is an antibody that gets taken into a cancer cell. The other is a radioactive actinium-255 atom which has a ten-day half-life, and then decays through a few different products, releasing four alpha particles, which rip through the cancer cell and kill it. Luckily alpha particles have only enough energy to destroy one cell, and then they run out of steam and become inert helium nuclei.
At Sloan-Kettering where this work was done, they applied for a patent. A clinical trial was conducted in 2002 with favorable results. There have also been some clinical trials in Australia, I believe.
As far as I am aware, this is a fantastic treatment, due to its being extremely specific, and is applicable to a wide range of cancers, but it's not used much. I would imagine the actinium-255 must be prepared through some process that would probably be very expensive. It would be great if some more affordable alternative could be found. It seems to me that were advanced nanotech available today, some suitable replacement for the radioactive actinium nucleus might be possible.
At Sloan-Kettering where this work was done, they applied for a patent. A clinical trial was conducted in 2002 with favorable results. There have also been some clinical trials in Australia, I believe.
As far as I am aware, this is a fantastic treatment, due to its being extremely specific, and is applicable to a wide range of cancers, but it's not used much. I would imagine the actinium-255 must be prepared through some process that would probably be very expensive. It would be great if some more affordable alternative could be found. It seems to me that were advanced nanotech available today, some suitable replacement for the radioactive actinium nucleus might be possible.
Nifty stuff over at Machine Phase blog
A couple of interesting things from Tom Moore's Machine Phase blog. One is a comparison between a carbon buckyball and a geometrically similar structure made from DNA using (what appears to be) Paul Rothemund's DNA origami technique. Note the teeny dot in the middle, that's the carbon buckytube.
The other is very interesting because it combines nanotech with my interest in 3d printers in an unexpected way. Specifically it's about using a 3d printer to print parts for an atomic-force microscope, using selective laser sintering. These microscopes typically cost hundreds of thousands of dollars. Hopefully this approach will make them much more affordable for universities, and perhaps high schools and even individual hobbyists.
The white plastic pieces were the things printed with the 3d printer. I always thought of SLS as something done with metal, but I guess it works with plastic too.
The other is very interesting because it combines nanotech with my interest in 3d printers in an unexpected way. Specifically it's about using a 3d printer to print parts for an atomic-force microscope, using selective laser sintering. These microscopes typically cost hundreds of thousands of dollars. Hopefully this approach will make them much more affordable for universities, and perhaps high schools and even individual hobbyists.
The white plastic pieces were the things printed with the 3d printer. I always thought of SLS as something done with metal, but I guess it works with plastic too.
Subscribe to:
Posts (Atom)